1SMCI.MI
Super Micro Computer, Inc.
MilanEUREQUITY
Technology
DELAYED
Last price
30.08
▼ 1.78 (5.59%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
31.86
Day high
31.42
Day low
29.26
Volume
77.90K
Market cap
$19.46B
P/E (TTM)
10.78
52W range
16.77 – 50.82
Trailing performance
Returnvs SPY
1W
-5.91%
-4.7%
1M
+16.02%
+12.7%
3M
+1.14%
-1.2%
6M
+20.09%
+8.2%
YTD
+24.50%
+12.5%
1Y
-14.12%
-34.3%
3Y
—
-75.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 1SMCI.MI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
79.01M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | LIANG CHARLES Chief Executive Officer |
— | 3.65K | — | Indirect |
| Aug 17, 26 | LIU LIANG CHIU-CHU SARA Director and Beneficial Owner of more than 10% of a Class of Security |
— | 3.65K | — | Direct |
| Aug 17, 26 | WEIGAND DAVID E Chief Financial Officer |
— | 6.50K | — | Direct |
| Aug 17, 26 | XIAO JIN Officer |
— | 4.00K | — | Direct |
| Aug 17, 26 | CHEUNG KENNETH Officer |
— | 2.25K | — | Direct |
| Aug 17, 26 | MALYALA VIKRANTH Officer |
— | 6.00K | — | Direct |
| Aug 17, 26 | THAUBERGER MATTHEW Officer |
— | 2.25K | — | Direct |
| Aug 10, 26 | LIANG CHARLES Chief Executive Officer |
— | 3.13K | — | Indirect |
| Aug 10, 26 | LIU LIANG CHIU-CHU SARA Director and Beneficial Owner of more than 10% of a Class of Security |
— | 3.13K | — | Direct |
| Aug 10, 26 | WEIGAND DAVID E Chief Financial Officer |
— | 1.48K | — | Direct |
| Aug 10, 26 | XIAO JIN Officer |
— | 2.99K | — | Direct |
| Aug 10, 26 | CHEUNG KENNETH Officer |
— | 4.68K | — | Direct |
| Aug 10, 26 | MALYALA VIKRANTH Officer |
— | 3.25K | — | Direct |
| Aug 10, 26 | THAUBERGER MATTHEW Officer |
— | 1.17K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CHEUNG KENNETH |
Officer | 63.77K | Conversion of Exercise of derivative security |
KAO GEORGE W |
Officer | 134.69K | Conversion of Exercise of derivative security |
LIANG CHARLES |
Chief Executive Officer | — | Conversion of Exercise of derivative security |
LIAW YIH SHYAN WALLY |
Director | 15.28M | Conversion of Exercise of derivative security |
LIN JUDY L |
Director | 60.32K | Conversion of Exercise of derivative security |
LIU LIANG CHIU-CHU SARA |
Director and Beneficial Owner of more than 10% of a Class of Security | 66.40M | Conversion of Exercise of derivative security |
LIU TALLY C |
Director | 288.74K | Conversion of Exercise of derivative security |
TUAN SHERMAN |
Director | 207.16K | Sale |
WEIGAND DAVID E |
Chief Financial Officer | 134.73K | Conversion of Exercise of derivative security |
XIAO JIN |
Officer | 194.64K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$19.46B
Enterprise value$24.47B
Revenue (TTM)$39.06B
Gross profit$4.23B
EBITDA$2.82B
Net income$2.20B
EPS (TTM)$2.79
Free cash flow$-8.23B
Total cash$7.52B
Total debt$9.31B
Book value / share$14.31
Shares outstanding646.87M
Float519.08M
Short % of float—
Dividend yield—
Beta (5Y)1.97
Valuation & profitability ratios
Trailing P/E10.78
Forward P/E—
PEG ratio—
Price / sales—
Price / book2.10
EV / revenue0.63
EV / EBITDA8.67
Gross margin10.82%
Operating margin13.38%
Profit margin5.71%
Return on equity21.47%
Return on assets7.88%
Debt / equity64.31
Current ratio3.87
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | — | $21.97B | $14.99B | $7.12B | $5.20B | — |
| Operating revenue | — | $21.97B | $14.99B | $7.12B | $5.20B | — |
| Cost of revenue | — | $19.54B | $12.93B | $5.84B | $4.40B | — |
| Gross profit | — | $2.43B | $2.06B | $1.28B | $800.00M | — |
| Research & development | — | $636.55M | $463.55M | $307.26M | $272.27M | — |
| Selling, general & admin | — | $540.38M | $387.09M | $214.61M | $192.56M | — |
| Total operating expense | — | $1.18B | $850.64M | $521.87M | $464.83M | — |
| Operating income | — | $1.25B | $1.21B | $761.14M | $335.17M | — |
| Net interest income | — | -$59.57M | -$19.35M | -$10.49M | -$6.41M | — |
| Pre-tax income | — | $1.21B | $1.21B | $754.30M | $336.83M | — |
| Tax provision | — | $156.85M | $63.29M | $110.67M | $52.88M | — |
| Net income | — | $1.05B | $1.15B | $640.00M | $285.16M | — |
| Net income to common | — | $1.05B | $1.15B | $640.00M | $285.16M | — |
| Basic EPS | 3.65 | 1.77 | 2.17 | 1.21 | — | +106.2% |
| Diluted EPS | 3.26 | 1.68 | 2.01 | 1.14 | — | +94.0% |
| EBIT | — | $1.27B | $1.23B | $764.79M | $343.25M | — |
| EBITDA | — | $1.33B | $1.27B | $799.69M | $375.72M | — |
| Basic shares | 601.81M | 593.66M | 555.88M | 529.25M | — | +1.4% |
| Diluted shares | 697.35M | 628.40M | 602.15M | 559.70M | — | +11.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.17B | $1.67B | $440.46M | $267.40M | +209.6% |
| Cash & short-term investments | $5.17B | $1.67B | $440.46M | $267.40M | +209.6% |
| Accounts receivable | $2.20B | $2.74B | $1.15B | $834.51M | -19.5% |
| Inventory | $4.68B | $4.33B | $1.45B | $1.55B | +8.0% |
| Total current assets | $12.30B | $8.93B | $3.18B | $2.81B | +37.7% |
| Property, plant & equipment | $798.18M | $414.01M | $290.24M | $285.97M | +92.8% |
| Total assets | $14.02B | $9.83B | $3.67B | $3.21B | +42.7% |
| Total current liabilities | $2.34B | $2.35B | $1.37B | $1.47B | -0.0% |
| Current debt | $75.06M | $402.35M | $170.12M | $449.15M | -81.3% |
| Long-term debt | $4.68B | $1.77B | $120.18M | $147.62M | +164.3% |
| Total debt | $4.78B | $2.18B | $290.30M | $596.76M | +118.9% |
| Total liabilities | $7.72B | $4.41B | $1.70B | $1.78B | +75.0% |
| Retained earnings | $3.43B | $2.59B | $1.43B | $942.92M | +32.8% |
| Shareholder equity | $6.30B | $5.42B | $1.97B | $1.43B | +16.3% |
| Working capital | $9.96B | $6.59B | $1.80B | $1.34B | +51.2% |
| Net tangible assets | $6.30B | $5.42B | $1.97B | $1.43B | +16.3% |
| Shares issued | 594.14M | 588.09M | 529.01M | 523.11M | +1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.05B | $1.15B | $640.00M | $285.16M | -9.0% |
| Depreciation & amortisation | $58.34M | $38.69M | $34.90M | $32.47M | +50.8% |
| Stock-based compensation | $314.45M | $231.51M | $54.43M | $32.82M | +35.8% |
| Change in working capital | $390.03M | -$3.75B | $26.87M | -$769.85M | +110.4% |
| Operating cash flow | $1.66B | -$2.49B | $663.58M | -$440.80M | +166.8% |
| Capital expenditure | -$127.21M | -$124.28M | -$36.79M | -$45.18M | -2.4% |
| Investing cash flow | -$183.21M | -$194.25M | -$39.49M | -$46.28M | +5.7% |
| Share buybacks | -$200.00M | $0 | -$150.00M | $0 | — |
| Financing cash flow | $2.02B | $3.91B | -$448.29M | $522.87M | -48.3% |
| Free cash flow | $1.53B | -$2.61B | $626.79M | -$485.98M | +158.7% |
| End cash position | $5.17B | $1.67B | $440.96M | $268.56M | +209.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $10.24B | $12.68B | $5.02B | $5.76B | $4.60B | — | -19.2% |
| Operating revenue | $10.24B | $12.68B | $5.02B | $5.76B | $4.60B | — | -19.2% |
| Cost of revenue | $9.22B | $11.88B | $4.55B | $5.21B | $4.16B | — | -22.4% |
| Gross profit | $1.02B | $798.57M | $467.37M | $544.10M | $440.22M | — | +27.6% |
| Research & development | $215.66M | $180.76M | $173.31M | $183.22M | $162.86M | — | +19.3% |
| Selling, general & admin | $177.15M | $143.51M | $111.80M | $132.49M | $130.58M | — | +23.4% |
| Total operating expense | $392.81M | $324.27M | $285.12M | $315.71M | $293.44M | — | +21.1% |
| Operating income | $625.87M | $474.30M | $182.26M | $228.39M | $146.78M | — | +32.0% |
| Net interest income | -$19.05M | $25.68M | -$24.93M | -$22.28M | $1.25M | — | -174.2% |
| Pre-tax income | $610.97M | $500.21M | $208.55M | $222.72M | $115.06M | — | +22.1% |
| Tax provision | $126.89M | $99.15M | $40.16M | $19.31M | $5.84M | — | +28.0% |
| Net income | $483.39M | $400.56M | $168.28M | $195.15M | $108.78M | — | +20.7% |
| Net income to common | $483.39M | $400.56M | $168.28M | $195.15M | $108.78M | — | +20.7% |
| Basic EPS | 0.81 | 0.67 | — | — | 0.18 | 0.54 | +20.9% |
| Diluted EPS | 0.72 | 0.60 | — | 0.31 | 0.17 | 0.51 | +20.0% |
| EBIT | $675.45M | $525.57M | $233.48M | $245.01M | $128.47M | — | +28.5% |
| EBITDA | $698.38M | $547.98M | $254.09M | $263.64M | $143.63M | — | +27.4% |
| Basic shares | — | — | — | 597.63M | — | — | — |
| Diluted shares | 692.19M | 693.99M | — | 624.67M | 621.81M | 636.05M | -0.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.29B | $4.09B | $4.20B | $5.17B | $2.54B | -68.5% |
| Cash & short-term investments | $1.29B | $4.09B | $4.20B | $5.17B | $2.54B | -68.5% |
| Accounts receivable | $8.41B | $11.00B | $2.53B | $2.20B | $2.64B | -23.5% |
| Inventory | $11.10B | $10.60B | $5.73B | $4.68B | $3.87B | +4.8% |
| Total current assets | $21.57B | $26.12B | $12.66B | $12.30B | $9.51B | -17.4% |
| Property, plant & equipment | $969.10M | $908.68M | $896.68M | $798.18M | $492.56M | +6.6% |
| Total assets | $23.45B | $28.00B | $14.39B | $14.02B | $10.74B | -16.2% |
| Total current liabilities | $8.12B | $15.40B | $2.35B | $2.34B | $1.43B | -47.2% |
| Current debt | $2.10B | $201.78M | $100.62M | $75.06M | $63.97M | +938.3% |
| Long-term debt | $6.68B | $4.68B | $4.68B | $4.68B | $2.43B | +42.8% |
| Total debt | $8.81B | $4.91B | $4.81B | $4.78B | $2.51B | +79.4% |
| Total liabilities | $15.88B | $21.01B | $7.86B | $7.72B | $4.36B | -24.4% |
| Retained earnings | $4.49B | $4.00B | $3.60B | $3.43B | $3.44B | +12.1% |
| Shareholder equity | $7.58B | $6.99B | $6.52B | $6.30B | $6.38B | +8.3% |
| Working capital | $13.45B | $10.73B | $10.31B | $9.96B | $8.09B | +25.3% |
| Net tangible assets | $7.58B | $6.99B | $6.52B | $6.30B | $6.38B | +8.3% |
| Shares issued | 601.38M | 598.93M | 596.84M | 594.14M | 596.77M | +0.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $483.39M | $400.56M | $168.28M | $195.15M | $108.78M | +20.7% |
| Depreciation & amortisation | $22.93M | $22.42M | $20.61M | $18.64M | $15.16M | +2.3% |
| Stock-based compensation | $125.93M | $90.48M | $89.14M | $83.61M | $84.70M | +39.2% |
| Change in working capital | -$7.34B | -$637.60M | -$1.23B | $620.48M | $312.40M | -1,051.7% |
| Operating cash flow | -$6.62B | -$23.90M | -$917.52M | $863.61M | $626.76M | -27,581.9% |
| Capital expenditure | -$80.28M | -$21.22M | -$32.27M | -$22.68M | -$32.70M | -278.3% |
| Investing cash flow | -$97.28M | -$46.22M | -$32.27M | -$78.68M | -$32.70M | -110.5% |
| Financing cash flow | $3.86B | $66.16M | -$18.66M | $1.85B | $512.05M | +5,733.2% |
| Free cash flow | -$6.70B | -$45.12M | -$949.79M | $840.93M | $594.06M | -14,740.1% |
| End cash position | $1.34B | $4.19B | $4.20B | $5.17B | $2.54B | -68.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $14.97B | +198.4% |
| Next quarter | — | — | $16.29B | +28.4% |
| Current year | — | — | $39.51B | +79.8% |
| Next year | — | — | $78.76B | +17.3% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders12.88%
Held by institutions70.52%
Institutions holding1.10K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
31.58
-4.75% from price
SMA 20
28.43
+12.05% from price
SMA 50
26.62
+19.70% from price
SMA 100
27.21
+10.53% from price
SMA 200
27.11
+17.53% from price
EMA 12
30.66
-1.88% from price
EMA 26
28.84
+4.28% from price
EMA 50
27.93
+7.68% from price
RSI (14)
59.1
Neutral
MACD (12,26,9)
1.81
Hist 0.37
ATR (14)
2.24
7.02% of price
Realised vol 30D
102.5%
Annualised
Bollinger upper
35.79
20, 2σ
Bollinger lower
21.08
20, 2σ
50 / 200 cross
Death
26.62 vs 27.11
Trend bias
Above 200
+17.53%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.79
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
102.5%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-63.0%
Peak to trough
Max drawdown 5Y
-67.3%
Peak to trough
ATR 14
2.24
7.02% of price
Beta (reported)
1.97
5Y monthly, from filing
Headlines
Net Asset Value(s)
Business Wire · 7m ago
AstraZeneca prices €2.55bn euro bond sale across four tranches
Proactive · 8m ago
Trees 'giving up': climate change hammers historic English gardens
AFP · 11m ago
Implantica to host Capital Markets Day in Stockholm on September 9
PR Newswire · 11m ago
Saudi Arabia to fund three new theme parks near Paris
Euronews · 12m ago
Cadeler: Q2 Earnings Snapshot
Associated Press · 13m ago
Solvonis raises £1.3m to fund three clinical programmes
Proactive · 13m ago
ZINZINO AB (PUBL.): INTERIM REPORT Q2 2026
PR Newswire · 14m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.